<DOC>
	<DOCNO>NCT00511173</DOCNO>
	<brief_summary>This prospective comparison clinician dose pharmacogenetic algorithm diagnose patient require warfarin therapy .</brief_summary>
	<brief_title>Comparison Warfarin Dosing Using Decision Model Versus Pharmacogenetic Algorithm</brief_title>
	<detailed_description>Diagnosed patient atrial fibrillation , pulmonary embolism , deep venous thrombosis require warfarin therapy consent tube blood DNA analysis drawn . The clinician dosing group eligible obtain pharmacogenetic result algorithm group warfarin pharmacogenetic SNPs perform integrated algorithm warfarin dose calculate . Outcomes patient receive method gather statistically analyze .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Warfarin</mesh_term>
	<criteria>Diagnosed patient atrial fibrillation , deep venous thrombosis , pulmonary embolism require warfarin therapy Patients atrial fibrillation , deep venous thrombosis , pullmonary embolism require warfarin therapy consent participate</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>mechanical valve</keyword>
</DOC>